celsentri 150 mg
glaxo smith kline (israel) ltd - maraviroc - film coated tablets - maraviroc 150 mg - maraviroc - maraviroc - celsentri is a ccr5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only ccr5-tropic hiv-1.• in treatment-naïve subjects, more subjects treated with celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• tropism testing with a highly sensitive tropism assay is required for the appropriate use of celsentri.
celsentri 300 mg
glaxo smith kline (israel) ltd - maraviroc - film coated tablets - maraviroc 300 mg - maraviroc - maraviroc - celsentri is a ccr5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only ccr5-tropic hiv-1.• in treatment-naïve subjects, more subjects treated with celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• tropism testing with a highly sensitive tropism assay is required for the appropriate use of celsentri.
stieva-a cream
glaxosmithkline inc - tretinoin - cream - 0.05% - tretinoin 0.05% - cell stimulants and proliferants
stieva-a cream
glaxosmithkline inc - tretinoin - cream - 0.025% - tretinoin 0.025% - cell stimulants and proliferants
stieva-a solution
glaxosmithkline inc - tretinoin - solution - 0.025% - tretinoin 0.025% - cell stimulants and proliferants
stieva-a gel
glaxosmithkline inc - tretinoin - gel - 0.025% - tretinoin 0.025% - cell stimulants and proliferants
stieva-a gel
glaxosmithkline inc - tretinoin - gel - 0.05% - tretinoin 0.05% - cell stimulants and proliferants
stieva-a cream
glaxosmithkline inc - tretinoin - cream - 0.01% - tretinoin 0.01% - cell stimulants and proliferants
stieva-a cream
glaxosmithkline inc - tretinoin - cream - 0.1% - tretinoin 0.1% - cell stimulants and proliferants
stievamycin regular gel
glaxosmithkline inc - tretinoin; erythromycin - gel - 0.025%; 4% - tretinoin 0.025%; erythromycin 4% - antibiotics